(Português) Identificado Medicamento Antiparasitário que ‘Mata’ Covid-19 em 48 Horas

ORIGINAL LANGUAGES, 6 Apr 2020

Notícias ao Minuto - TRANSCEND Media Service

Medicamento dá pelo nome de Ivermectin, mas cientistas avisam que, “realisticamente, demorará algum tempo para que uma vacina esteja amplamente disponível”.

© Getty Images

3 abr 2020 – Um estudo conjunto levado a cabo pelo Monash Biomedicine Discovery Institute e pelo Peter Doherty Institute of Infection and Immunity, na Austrália, identificou um medicamento antiparasitário capaz de ‘matar’ a Covid-19 nos testes laboratoriais no espaço de 48 horas.

Kylie Wagstaff, uma das responsáveis pelo estudo, sublinhou, no entanto, em declarações ao jornal australiano The Canberra Times, que ainda é preciso saber qual a dosagem correta de Ivermectin a usar em humanos para curar por completo a infeção.

“Descobrimos que, mesmo uma dose única, poderia remover, essencialmente, todo o RNA viral no espaço de 48 horas, e que, mesmo num período de 24 horas, é possível haver uma redução verdadeiramente significativa”, afirmou.

“Num período em que temos uma pandemia de global e em que não há qualquer tratamento aprovado, se tivéssemos um composto que estivesse já disponível em todo o mundo, isso poderia ajudar as pessoas mais cedo”, acrescentou.

Kylie Wagstaff deixou, no entanto, um aviso: “Realisticamente, demorará algum tempo para que uma vacina esteja amplamente disponível”.

Go to Original – noticiasaominuto.com


Tags: , , , , , , , , , , , , , , , ,

 

Share this article:


DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.


There are no comments so far.

Join the discussion!

We welcome debate and dissent, but personal — ad hominem — attacks (on authors, other users or any individual), abuse and defamatory language will not be tolerated. Nor will we tolerate attempts to deliberately disrupt discussions. We aim to maintain an inviting space to focus on intelligent interactions and debates.

*

code

This site uses Akismet to reduce spam. Learn how your comment data is processed.